Perioperative oral administration of Cystine and Theanine enhances recovery after thoracoscopic esophagectomy
Not Applicable
Completed
- Conditions
- esophageal cancer
- Registration Number
- JPRN-UMIN000024849
- Lead Sponsor
- Tohoku University Division of Advanced Surgical and Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Active infection (2) Poorly controlled hypertension (3) Poorly controlled diabetes mellitus (4) Patients with severe underlying circulatory disease (5) Participate in other study (6) Inability to take food orally (7) Need for intravenous amino acid infusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method physical activity measured by an activity monitor
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cystine and theanine's effects on postoperative recovery in thoracoscopic esophagectomy patients with esophageal cancer?
How does perioperative cystine and theanine administration compare to standard-of-care nutritional support in enhancing recovery after thoracoscopic esophagectomy for esophageal cancer?
Are there specific biomarkers that can predict patient response to cystine and theanine supplementation in esophageal cancer surgery recovery?
What are the potential adverse events associated with high-dose cystine and theanine administration in esophageal cancer patients undergoing thoracoscopic esophagectomy?
What other amino acid combinations or nutraceutical approaches have shown promise in postoperative recovery for esophageal cancer patients undergoing minimally invasive surgery?